Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1987-10-26
1988-09-06
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424491, 424493, 514908, A61K 950
Patent
active
047692502
ABSTRACT:
Formulations consisting of phospholipid bilayer membrane particles made from mixtures of anionic and neutral phospholipids encapsulating anthracycline anti-neoplastic agents, suspended in a low ionic strength aqueous phase, are described. In a preferred embodiment, the particles are in the form of vesicles which comprise daunorubicin, distearoyl phosphatidylglycerol and distearoyl phosphatidylcholine, the mol ratio of daunorubicin to distearoyl phosphatidylglycerol is at least about 1:1.25, and the suspending medium is an aqueous lactose solution containing a small amount of base.
REFERENCES:
patent: 4310505 (1982-01-01), Baldeschwieler et al.
patent: 4331654 (1982-05-01), Morris
patent: 4356167 (1982-10-01), Kelly
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4427649 (1984-01-01), Dingle et al.
patent: 4427664 (1984-01-01), Horton et al.
patent: 4438105 (1984-03-01), Suarato et al.
patent: 4474945 (1984-10-01), Yoshimoto et al.
patent: 4619794 (1986-10-01), Hauser
Mosijezuk, et al., Cancer, 44, pp. 1582-1587, (1979).
Lefrak, et al., Cancer, 32, pp. 302-314, (1973).
Forssen and Tokes, Cancer Res., 43, pp. 546-550, (1983).
Gabizon et al., Cancer Res., 43, pp. 4730-4735, (1983).
Gregoriadis, "Liposome Technology", vol. 1, Preparation of Liposomes, (Boca Raton, Fla.: CRC Press Inc., 1984); Strauss, Freezing and Thawing of Liposome Suspensions", pp. 197-219.
Gabizon et al., Br. J. Cancer, 51, pp. 681-689, (1985).
M. R. Mauk and R. C. Gamble, Anal. Bioc., 94, pp. 302-307, (1979).
Gabizon et al., Cancer Res., 42, 4734-4739, (1982).
Griffin Ronald W.
Vestar, Inc.
LandOfFree
Antracycline antineoplastic agents encapsulated in phospholipid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antracycline antineoplastic agents encapsulated in phospholipid , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antracycline antineoplastic agents encapsulated in phospholipid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1606148